Does targeted radionuclide therapy using 177Lutetium induce immune activation upon treatment?

Thomas Ertveldt, Ahmet Krasniqi, Marleen Keyaerts, Cleo Goyvaerts, Quentin Lecocq, Yannick De Vlaeminck, Robin Maximilian Awad, Lien De Beck, Yana Dekempeneer, Nick Devoogdt, Matthias D'Huyvetter, Karine Breckpot

Onderzoeksoutput: Poster

1 Afgelopen
1 Actief

1 resultaten

Filter

Actief
SRP50: SRP-Onderzoekszwaartepunt: Exploiting Peptides: Protein Binders, Modulators and Inhibitors for Imaging and Therapy [Exploit-PeptIT]
Ballet, S., Caveliers, V., Hernot, S., Versées, W., Vinken, M., Muyldermans, S., Devoogdt, N., Bridoux, J. & Martin, C.
1/03/19 → 30/09/25
Project: Fundamenteel